EBV renders B cells susceptible to HIV-1 in humanized mice.
Donal McHughRenier MyburghNicole CaduffMichael SpohnYik Lim KokChristian W KellerAnita MurerBithi ChatterjeeJulia RühlChristine EngelmannObinna ChijiokeIsaak QuastMohaned ShilaihVictoria P StrouvelleKathrin NeumannThomas MenterStephan DirnhoferJanice Kp LamKwai Fung HuiSimon BredlErika SchlaepferSilvia SorceAndrea ZbindenRiccarda CapaulJan D LünemannAdriano AguzziAlan Kwok Shing ChiangWerner KempfAlexandra TrkolaKarin J MetznerMarkus Gabriel ManzAdam GrundhoffRoberto F SpeckChristian MünzPublished in: Life science alliance (2020)
HIV and EBV are human pathogens that cause a considerable burden to worldwide health. In combination, these viruses are linked to AIDS-associated lymphomas. We found that EBV, which transforms B cells, renders them susceptible to HIV-1 infection in a CXCR4 and CD4-dependent manner in vitro and that CXCR4-tropic HIV-1 integrates into the genome of these B cells with the same molecular profile as in autologous CD4+ T cells. In addition, we established a humanized mouse model to investigate the in vivo interactions of EBV and HIV-1 upon coinfection. The respective mice that reconstitute human immune system components upon transplantation with CD34+ human hematopoietic progenitor cells could recapitulate aspects of EBV and HIV immunobiology observed in dual-infected patients. Upon coinfection of humanized mice, EBV/HIV dual-infected B cells could be detected, but were susceptible to CD8+ T-cell-mediated immune control.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- epstein barr virus
- hiv testing
- human immunodeficiency virus
- hiv aids
- hepatitis c virus
- men who have sex with men
- diffuse large b cell lymphoma
- endothelial cells
- mouse model
- public health
- healthcare
- south africa
- metabolic syndrome
- stem cells
- risk factors
- monoclonal antibody
- climate change
- single molecule
- gram negative
- antimicrobial resistance